Molbio Diagnostics IPO Reservation
The Molbio Diagnostics IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 1,16,46,246 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
The Retail Individual Investor (RII) category has the highest allocation with 40,69,004 shares, representing 34.94% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 23,25,146 shares (19.96%), while Non-Institutional Investors (NIIs) receive 17,43,859 shares (14.97%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 11,62,573 shares (9.98%) and Small Non-Institutional Investors (SNII) with 5,81,286 shares (4.99%).
The IPO also includes a dedicated reservation for Employees, comprising 20,520 shares (0.18%). This category-wise reservation provides a clear view of how the IPO shares are distributed among eligible investor groups.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Anchor Investors | 3487717 | 29.95 | 0 |
| Qualified Institutions | 2325146 | 19.96 | 0 |
| Non-Institutional | 1743859 | 14.97 | 0 |
| BNII | 1162573 | 9.98 | 0 |
| SNII | 581286 | 4.99 | 0 |
| Retail Investors | 4069004 | 34.94 | 0 |
| Employees | 20520 | 0.18 | 0 |
| Total | 11646246 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Molbio Diagnostics IPO?
The Retail Individual Investor (RII) quota in the Molbio Diagnostics IPO comprises 40,69,004 equity shares, representing 34.94% of the total IPO issue.
What is the reservation for QIBs in the Molbio Diagnostics IPO?
Qualified Institutional Buyers (QIBs) have been allocated 23,25,146 equity shares, representing 19.96% of the total IPO issue.
What is the reservation for HNI investors in the Molbio Diagnostics IPO?
The Non-Institutional Investors (NII) category has been allotted 17,43,859 equity shares (14.97%). This category is further divided into: Big HNI (bNII): 5,81,286 shares (9.98%) Small HNI (sNII): 11,62,573 shares (4.99%).
What is the category-wise reservation in the Molbio Diagnostics IPO?
The Molbio Diagnostics IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 23,25,146 shares (19.96%). Non-Institutional Investors (NII): 17,43,859 shares (14.97%). Retail Individual Investors (RII): 40,69,004 shares (34.94%). Employees: 20,520 shares (0.18%).
Is there an employee reservation in the Molbio Diagnostics IPO?
Yes. The Molbio Diagnostics IPO has reserved 20,520 equity shares, representing 0.18% of the total issue for eligible employees.
Is there a shareholder quota in the Molbio Diagnostics IPO?
No. The Molbio Diagnostics IPO does not include a shareholder reservation.